The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Seattle Children’s Research Institute, the research division of Seattle Children’s Hospital and a leader in pediatric research, and Genezen, a gene ...
read more
Akari Therapeutics, Plc and Peak Bio Inc. announced a definitive agreement to merge as equals in an all-stock transaction. The combined entity will ...
read more
ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate ...
read more
Thursday, February 29, 2024
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-...
read more
Wednesday, February 28, 2024
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral gene therapies with minimally-invasive delivery ...
read more
Friday, February 23, 2024
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-...
read more
Thursday, February 22, 2024
AstraZeneca announced the successful completion of the acquisition of Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company ...
read more
Tuesday, February 20, 2024
The FDA approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is ...
read more
Friday, February 16, 2024
Astellas Pharma Inc. and Kelonia Therapeutics announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas) and Kelonia have ...
read more
Wednesday, February 14, 2024
Alys Pharmaceuticals, Inc., an immuno-dermatology focused company, launches with an R&D pipeline enabled by multiple platform technologies and a $100 ...
read more
Wednesday, February 14, 2024
AbbVie announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie.
read more
Friday, February 09, 2024
BioNTech SE and Autolus Therapeutics plc announced a strategic collaboration aimed at advancing both companies’ autologous CAR-T programs towards ...
read more
Tuesday, February 06, 2024
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for ...
read more
Tuesday, February 06, 2024
CEL-SCI Corporation announced that its Multikine® (Leukocyte Interleukin, Injection)* cGMP state-of-the-art dedicated manufacturing facility ...
read more
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...
read more